Insulin glargine (HOE901) - First responsibilities: understanding the data and ensuring safety

被引：11
作者：
Buse, J [1 ]
机构：
[1] Univ N Carolina, Diabet Care Ctr, Durham, NC 27713 USA
来源：
DIABETES CARE | 2000年 / 23卷 / 05期
关键词：
D O I：
10.2337/diacare.23.5.576
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：576 / 578
页数：3
相关论文
共 5 条
[1]   Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo [J].
Heinemann, L ;
Linkeschova, R ;
Rave, K ;
Hompesch, B ;
Sedlak, M ;
Heise, T .
DIABETES CARE, 2000, 23 (05) :644-649
[2]   Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime [J].
Lalli, C ;
Ciofetta, M ;
del Sindaco, P ;
Torlone, E ;
Pampanelli, S ;
Compagnucci, P ;
Cartechini, MG ;
Bartocci, L ;
Brunetti, P ;
Bolli, GB .
DIABETES CARE, 1999, 22 (03) :468-477
[3]   Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes [J].
Pieber, TR ;
Eugene-Jolchine, I ;
Derobert, E .
DIABETES CARE, 2000, 23 (02) :157-162
[4]   Less hypoglycemia with insulin glargine in intensive insulin therapy for the 1 diabetes [J].
Ratner, RE ;
Hirsch, IB ;
Neifing, JL ;
Garg, SK ;
Mecca, TE ;
Wilson, CA .
DIABETES CARE, 2000, 23 (05) :639-643
[5]   Insulin lispro in CSII - Results of a double-blind crossover study [J].
Zinman, B ;
Tildesley, H ;
Chiasson, JL ;
Tsui, E ;
Strack, T .
DIABETES, 1997, 46 (03) :440-443
1